Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DXC
DXC logo

DXC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy DXC Technology Co (DXC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
9.910
1 Day change
6.90%
52 Week Range
16.450
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

DXC Technology is not a good buy right now for a beginner, long-term investor with $50,000-$100,000 available. The stock is trading in a weak trend, analysts have repeatedly cut targets, and the current setup does not show a strong enough fundamental or technical entry. If the investor is unwilling to wait for a better entry, this is still not an attractive immediate buy. The most direct call is to hold off rather than buy now.

Technical Analysis

DXC is technically mixed to weak. MACD histogram is positive and expanding, which shows some short-term momentum improvement, but RSI at 45.86 is neutral and does not confirm strength. The moving average structure is bearish, with SMA_200 > SMA_20 > SMA_5, which points to a broader downtrend. Price at 9.27 is below the nearest resistance at 9.53 and above pivot support at 8.967, so the stock is stuck in a narrow zone without clear bullish confirmation. Short-term modeled trend suggests only modest upside over the next week and month, but not enough to call this a strong buy.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is somewhat mixed. The open interest put-call ratio of 0.71 leans mildly bullish on positioning, but the option volume put-call ratio of 2.0 shows heavier put activity today, suggesting near-term caution or hedging. High implied volatility at 67.71 and IV percentile at 84.92 indicate elevated option pricing. Overall, options data does not support a strong bullish conviction.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
7

Positive Catalysts

  • ["DXC completed a cloud migration for Telenor Sweden, improving efficiency and supporting future AI capabilities.", "News flow around the Telenor Sweden partnership suggests DXC is still winning modernization work in cloud services.", "MACD histogram is positive and expanding, showing improving near-term momentum."]

Neutral/Negative Catalysts

  • ["Analysts have recently cut price targets multiple times, signaling worsening Wall Street expectations.", "BMO noted DXC missed Q4 revenue expectations and gave FY27 guidance below expectations on both revenue and EBIT margins.", "The moving-average structure remains bearish, indicating the broader trend is still weak.", "Option volume shows more puts than calls today, which leans cautious.", "Hedge funds and insiders are neutral, so there is no notable supportive buying trend.", "No significant politician or congress trading activity was reported."]

Financial Performance

No detailed financial snapshot was available because of the provided data error, so the latest quarter cannot be fully assessed from the supplied financial table. However, the most recent analyst commentary indicates DXC missed Q4 revenue expectations, mainly in Global Infrastructure Services, and initial FY27 guidance came in below expectations for both revenue and EBIT margins. The latest quarter season referenced by analysts is Q4, and the commentary points to slowing growth and weaker-than-expected profitability outlook.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Wall Street sentiment has turned more cautious. Morgan Stanley cut its target to $9 from $15 and kept Equal Weight. BMO cut its target to $10 from $17 and kept Market Perform after the Q4 revenue miss and weak FY27 guidance. Stifel lowered its target to $12 from $14 and kept Hold. TD Cowen lowered its target to $14 from $15 and kept Hold. Overall, the analyst trend is negative with repeated target cuts and mostly neutral-to-bearish ratings. Pros: valuation expectations may already be compressed and DXC still has contract wins in cloud modernization. Cons: target cuts, weak revenue execution, and below-consensus guidance show limited near-term upside.

Wall Street analysts forecast DXC stock price to rise
7 Analyst Rating
Wall Street analysts forecast DXC stock price to rise
0 Buy
6 Hold
1 Sell
Hold
Current: 9.270
sliders
Low
14
Averages
14.71
High
16
Current: 9.270
sliders
Low
14
Averages
14.71
High
16
Morgan Stanley
James Faucette
Equal Weight
downgrade
$15 -> $9
AI Analysis
2026-05-14
Reason
Morgan Stanley
James Faucette
Price Target
$15 -> $9
AI Analysis
2026-05-14
downgrade
Equal Weight
Reason
Morgan Stanley analyst James Faucette lowered the firm's price target on DXC Technology to $9 from $15 and keeps an Equal Weight rating on the shares.
BMO Capital
Market Perform
downgrade
$17 -> $10
2026-05-11
Reason
BMO Capital
Price Target
$17 -> $10
2026-05-11
downgrade
Market Perform
Reason
BMO Capital lowered the firm's price target on DXC Technology to $10 from $17 and keeps a Market Perform rating on the shares. The company missed Q4 revenue expectations, primarily in the Global Infrastructure Services segment business, while its initial FY27 guidance was below expectations on both revenues and EBIT margins, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DXC
Unlock Now

People Also Watch